Free Trial

JPMorgan Chase & Co. Increases Itron (NASDAQ:ITRI) Price Target to $155.00

Itron logo with Computer and Technology background

Key Points

  • JPMorgan Chase & Co. has increased Itron's price target to $155.00, suggesting a potential upside of 15.83% from its previous close.
  • Other analysts have also issued positive ratings on Itron, with upgrades including a "buy" rating and price targets ranging from $130.00 to $155.00.
  • Itron's most recent quarterly earnings report showed an EPS of $1.62, exceeding estimates, though revenue was slightly down year-over-year.
  • Interested in Itron? Here are five stocks we like better.

Itron (NASDAQ:ITRI - Get Free Report) had its price target boosted by research analysts at JPMorgan Chase & Co. from $145.00 to $155.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an "overweight" rating on the scientific and technical instruments company's stock. JPMorgan Chase & Co.'s price objective would suggest a potential upside of 15.83% from the company's previous close.

Several other analysts also recently weighed in on the stock. Wall Street Zen upgraded shares of Itron from a "hold" rating to a "buy" rating in a research report on Friday, October 3rd. TD Cowen lifted their price objective on shares of Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research report on Friday, June 20th. Stephens reissued an "equal weight" rating and set a $130.00 target price on shares of Itron in a research note on Tuesday, October 7th. Guggenheim reissued a "buy" rating and set a $155.00 target price (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. Finally, Roth Capital raised their target price on shares of Itron from $130.00 to $150.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $138.10.

Check Out Our Latest Stock Analysis on ITRI

Itron Stock Performance

NASDAQ:ITRI traded up $0.10 during mid-day trading on Thursday, hitting $133.82. The stock had a trading volume of 196,483 shares, compared to its average volume of 601,826. The stock has a market capitalization of $6.12 billion, a price-to-earnings ratio of 22.94, a P/E/G ratio of 0.72 and a beta of 1.48. The company has a 50 day simple moving average of $123.77 and a 200-day simple moving average of $120.29. Itron has a 52 week low of $90.11 and a 52 week high of $140.04. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48.

Itron (NASDAQ:ITRI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.29. The firm had revenue of $606.76 million for the quarter, compared to the consensus estimate of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. Itron's quarterly revenue was down .4% compared to the same quarter last year. During the same period last year, the firm posted $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, research analysts expect that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, SVP John F. Marcolini sold 565 shares of Itron stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $70,800.15. Following the transaction, the senior vice president owned 14,396 shares of the company's stock, valued at $1,803,962.76. The trade was a 3.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Donald L. Reeves III sold 547 shares of Itron stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $68,544.57. Following the completion of the transaction, the senior vice president directly owned 19,604 shares in the company, valued at $2,456,577.24. This represents a 2.71% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 3,037 shares of company stock worth $380,566. 1.45% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Inspire Investing LLC increased its position in shares of Itron by 23.7% in the third quarter. Inspire Investing LLC now owns 13,153 shares of the scientific and technical instruments company's stock worth $1,638,000 after acquiring an additional 2,516 shares in the last quarter. Harbor Capital Advisors Inc. increased its position in shares of Itron by 7.0% in the third quarter. Harbor Capital Advisors Inc. now owns 13,153 shares of the scientific and technical instruments company's stock worth $1,638,000 after acquiring an additional 863 shares in the last quarter. Swedbank AB increased its position in shares of Itron by 1,191.1% in the third quarter. Swedbank AB now owns 58,100 shares of the scientific and technical instruments company's stock worth $7,237,000 after acquiring an additional 53,600 shares in the last quarter. Farther Finance Advisors LLC increased its position in shares of Itron by 260.2% in the third quarter. Farther Finance Advisors LLC now owns 4,466 shares of the scientific and technical instruments company's stock worth $556,000 after acquiring an additional 3,226 shares in the last quarter. Finally, Flputnam Investment Management Co. increased its position in shares of Itron by 74.7% in the third quarter. Flputnam Investment Management Co. now owns 31,009 shares of the scientific and technical instruments company's stock worth $3,862,000 after acquiring an additional 13,258 shares in the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

About Itron

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Read More

Analyst Recommendations for Itron (NASDAQ:ITRI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.